Innovative Technology Bringing Hope to Patients
By analyzing big data from the TCGA database, we identify novel DNA methylation biomarkers. These biomarkers are validated using plasma free DNA from both cancer patients and healthy individuals. We aim to develop an early cancer detection and post-treatment monitoring system, along with automated analysis equipment. This approach is expected to simplify the patient testing process, accelerate diagnosis by doctors, increase cancer screening rates, and improve patient prognosis.
Testing Advantages
- No time restrictions
- No fasting required
- Convenient and fast
- Safe and comfortable
- Precise and professional
- Innovative patents
Improving Cancer Survival Rates
There is a clinical need for novel and objective precision testing methods to improve cancer screening accuracy. By developing a high-acceptance, highly accurate testing method, we can detect early-stage cancer precisely and provide timely treatment, preventing patients from progressing to advanced stages. This is key to improving cancer survival rates.
